Sponsored Publications Archives - Page 21 of 21 - European Biotechnology Magazine

Stay up to date every week with the european biotechnology newsletter.

Instagram

This field is for validation purposes and should be left unchanged.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Stay up to date every week with the european biotechnology newsletter.

Name

This field is for validation purposes and should be left unchanged.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

go to the article

go back to the homepage

BIOCOM CARD
Newsletter
Advertising
Job Market
Shop

Latest news
Background
Opinion
The Mag
Euro Biotech Guide
Market Place
Associations
Service
Events
Search
Menu Menu

14 Must-Haves to Boost the Efficiency of Your Data Room

Sponsored Publications

Stop wasting time with data room software that doesn’t really improve your workflow.

17 October 2016

https://european-biotechnology.com/wp-content/uploads/2024/04/Drooms_Whitepaper.png 360 640 Maren Kühr /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Maren Kühr2016-10-17 16:12:172016-10-17 16:12:1714 Must-Haves to Boost the Efficiency of Your Data Room

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies

Sponsored Publications

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

29 September 2016

https://european-biotechnology.com/wp-content/uploads/2024/04/WhitePaper_Jackson_Labs__May16_.jpg 360 640 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2016-09-29 14:43:002016-09-29 14:43:00Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies

TOP3 CHALLENGES FOR COMMERCIAL TEXT MINERS

Sponsored Publications

How Content Access and Manual Process Hinder Mining Efforts

27 September 2016

https://european-biotechnology.com/wp-content/uploads/2024/04/WhitepaperRightsEBSIN.jpg 360 640 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2016-09-27 14:45:132016-09-27 14:45:13TOP3 CHALLENGES FOR COMMERCIAL TEXT MINERS

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

Sponsored Publications

14 June 2016

/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png 0 0 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2016-06-14 18:09:092016-06-14 18:09:09Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

Page 21 of 21«‹19 2021

LATEST NEWS

Sofinnova Partners

Sofinnova Partners surpasses target with €650m fu...

Medicxi

Medicxi announces new €500m biotech investment fu...

banner background, health care researchers working in life science laboratory, medical science technology research work for test a vaccine, coronavirus covid-19 vaccine protection cure treatment

chokniti - Adobe Stock

Virometix: US$15m for Synthetic Vaccines

MAGAZINE

1 / 4

Investors are showing enormous interest in the topic of longevity, as well as in combating chronic diseases. This is because these diseases have a negative impact on life expectancy. The USA and China … more ➔

2 / 4

This issue focuses on the art of upscaling industrial biotechnology in Europe, the impact of the Trump factor on the life sciences and the European Commission's new billion-euro fund for emerging … more ➔

3 / 4

This issue offers insights into Europe's fight for green solutions for a bioeconomy, antimicrobial resistance and how Europe is preparing for the next pandemic. more ➔

4 / 4

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … more ➔

14 Must-Haves to Boost the Efficiency of Your Data Room

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies

TOP3 CHALLENGES FOR COMMERCIAL TEXT MINERS

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

Sofinnova Partners surpasses target with €650m fu...

Medicxi announces new €500m biotech investment fu...

Virometix: US$15m for Synthetic Vaccines

How T3 scaled faster in Basel’s biotech labs

Innovative Approaches to Gene Therapy